Issues that should be considered when designing an equity-based long-term incentive plan for a private company.

In the latest NACD BoardTalk blog, A&M Managing Directors Matt Campbell and Colin Harvey explore five actions to ensure that your next deal doesn’t miss the human side of mergers and acquisitions (M&A).

Establishing an equity-based long-term incentive plan in private companies presents unique design and planning issues.

A&M’s Ron Thompson, Managing Director and Lead of the Restructuring and Insolvency practice in Asia, speaks about the likelihood of holistic restructurings and the risk of insolvency for distressed developers in China. 

The A&M interim QRA vice president stepped in to redesign the department of 400 people and initiated process improvement projects. The goal was to simplify the processes to allow the department to address complaints, remediation cases and recalls in a more efficient manner.

Merger and acquisition (M&A) activity in Germany sustained its strong pace in the first six months of 2022, but dealmaking in the second half of the year faces several challenging factors. Some of these headwinds are more pronounced in Europe because of the Russia-Ukraine war and the resulting impacts on supply chains and energy prices, particularly on the availability of natural gas.

If you import or export goods, you will now need to register with the Customs Declaration Service (CDS) to make your import declarations.

Who's Who Legal recognized A&M Managing Director Vishal Narula as a Future Leader in the 2022 Competition Economists guide.

Exploring the market outlook for Hong Kong and Asian investment and the key tax considerations that investors should be aware of.

A&M’s Managing Director Keith Williamson and Senior Director Henry Chambers were invited by Tom Fox, Founder of the Compliance Podcast Network, to discuss Threatscape 2022, a report that examines risks in FCPA investigations, data privacy and protection and digital asset fraud, on the FCPA Compliance Report Podcast.

A&M Healthcare Industry Group Senior Directors, Marthe H. Haverkamp, M.D., Ph.D., and Jon Masoudi, M.D., M.B.A., together with Ed McGookin, M.D., M.H.C.D.S, Chief Medical Officer of Coastal Medical, a Lifespan ACO, published an article in Medhealth Outlook. 

Coming off a record year of dealmaking globally, 2022 still has a chance to be one of the better periods of activity in several years. In Spain, Mergers and Acquisitions (M&A) continued their momentum from 2021 with 382 deals announced in the first half of 2022. That’s nearly identical to 2021’s 384 first-half deals.

In the August edition of the A&M Taxand London Asset Managers Briefing Note our experts discuss: sovereign immunity reform consultation, ATAD 3, the recent Bluecrest Capital Management v HMRC case, British Venture Capital Association’s dialogue with HMRC on the changes to carried interest guidance and more.